In a bid to treat blindness, Life Biosciences will try out potent cellular reprogramming technology on volunteers.
Morning Overview on MSN
Scientists trial shocking ER-100 drug that could reverse human aging
For decades, the idea of a drug that could rewind aspects of human aging has belonged more to science fiction than hospital formularies. That boundary is starting to blur as a gene therapy called ...
"Aging has a relatively simple explanation and is apparently reversible." The post Scientists Testing Controversial Human ...
Precise methods for shredding or repairing and replacing specific cancer-causing proteins in a malignant cell, developed at ...
Money Talks News on MSN
Scientist claims humans could live 20,000 years with new technology
British scientist says humans could live 20,000 years through DNA reprogramming and cellular repair technology that eliminates aging.
IND clearance marks the first ever cellular rejuvenation therapy using partial epigenetic reprogramming to reach human ...
Scientists at Life Biosciences are testing a controversial compound, ER-100, aimed at reversing human aging by resetting cells.
News Medical on MSN
Lund researchers create "recipe book" for reprogramming immune cells to fight disease
In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the "recipe" for the transformation. Researchers at Lund University have now created ...
Type 1 diabetes (T1D) is an autoimmune disorder characterized by the specific destruction of insulin-producing pancreatic ...
Dr. Maik Luu discusses how postbiotics can be used to reprogram CAR T cells to promote anti-tumor function and what further ...
Life Biosciences plans to begin human clinical trials of a cellular rejuvenation therapy in optic neuropathies after ...
STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today announced a strategic collaboration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results